compounding glp-1 enforcement news The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in bio FDA Escalates Enforcement Against Compounded

For Medicare Part D, this model will be implemented in January 2027, following a separate short-term demonstration that will allow Medicare Part D enrollees to access obesity drugs beginning in July 2026

We still need larger and longer studies, especially in patients with more active lupus, severe lupus nephritis, and complex autoimmune disease

Global Clinical Lead, Clinical Development, Migraine & Pain Clinical Supply Manager International Product Manager, MEQU/1947 Regulatory Affairs Manager, Chr

It helps in treating other diseases, the most important of which are skin problems, in addition to other diseases such as: Parkinson's disease treatment

Vitamin E is an antioxidant and can increase fertility for both men and women

These powerful drugs carry very real risks for people with the condition